Skip to main content

PVM’s Oncology Team Buoys Purdue Institute for Cancer Research 5K Fundraising Run

Members of PVM’s Team Werling gathered for a group photo sporting their custom T-shirts the day before they ran in the annual 5K Challenge fundraising run April 12 to support the Purdue Institute for Cancer Research.
Members of PVM’s Team Werling gathered for a group photo sporting their custom T-shirts the day before they ran in the annual 5K Challenge fundraising run April 12 to support the Purdue Institute for Cancer Research.

It is no surprise that the members of Purdue’s Werling Comparative Oncology Research Center (WCORC) in the College of Veterinary Medicine would not back down from a challenge, especially when it comes to supporting innovative cancer research. So, true to form, about two-dozen representatives of the center could be found out on the course Saturday, April 12, participating in the 17th annual 5K Challenge fundraising run to support the Purdue Institute for Cancer Research.

The event, which started and ended just west of the Rankin Track and Field, near the Cordova Recreational Sports Center, brought together the Boilermaker community and beyond to raise support for the fight against cancer. Among the 1422 registrants this year, 23 represented the Werling Comparative Oncology Research Center. They included Dr. Deborah Knapp and her husband Jim; Dr. Marejka Shaevitz; Dr. Erin Stewart; Drs. Shawna Klahn and Nick Dervisis and their family; Dr. Zachary Yaufman; Drs. Mike and Erica Childress and their family; Drs. Chris and Carrie Fulkerson and family; Dr. Conor Williams; Seung-Oe Lim, PhD, a key collaborator on the faculty of the Purdue College of Pharmacy; Jeri Tullius, RVT and her husband Bob; Patty Bonney, RVT; and Erica Fesler, RVT.

One of the team members, Dr. Marejka Shaevitz, clinical assistant professor of oncology, has her own deeply personal story that relates to her participation. Dr. Shaevitz won a battle with cancer after she was diagnosed with Hodgkin’s lymphoma, a rare form of cancer that affects the immune system.

“As both a cancer survivor and veterinary oncologist who works to move cancer therapy forward for pets and people, I was overwhelmed at the level of support for the Challenge 5k and honored to be a part of the community supporting the important research taking place through the Purdue Institute for Cancer Research,” said Dr. Shaevitz, reflecting on her participation in the run.

Dr. Knapp served as the Team Captain leading the pack of WCORC participants. Together the group helped contribute to the total of $49,764 that was raised for the Purdue Institute for Cancer Research by a total of 78 teams.

This annual event brings extraordinary hope to survivors and their loved ones, emphasizing that small contributions can spark major change in the fight against cancer. Since it started in 2008, the 5K Challenge has generated more than $1 million in funding to advance lifesaving science at the Purdue Institute for Cancer Research. By bringing real hope to survivors and their loved ones, the event proves that small steps lead to big change and PVM is proud and thankful to be so admirably represented by the veterinary oncology team that stepped up to the challenge!

Writer(s): Caroline Keim | pvmnews@purdue.edu

Recent Stories

Purdue Veterinary Medicine Fosters Learning and Engagement linking people, animals and agriculture at Indiana State Fair

In just more than two weeks’ time during the month of August, the 2026 Indiana State Fair served up an abundance of fun, food, and festivities, and in the midst of it all, faculty, staff and students from the Purdue University College of Veterinary Medicine were visible and vibrant participants. Purdue Veterinary Medicine representatives made a difference in a variety of ways, from providing veterinary care for the animals on the fairgrounds, to helping animal agriculture organizations as volunteers, to conducting veterinary checks on animals at the annual 4-H State Fair Dog Show and Cat Show.

“Paws Up” for Jennifer Danaher – brought to you by the PVM Wellness Committee

This week we express our gratitude to Jennifer Danaher, who is department secretary for Veterinary Clinical Sciences.

‘Purdue Pursuits’: A PVM angle on Purdue’s teaching and learning reading groups

Crafting meaningful and engaging course experiences has been at the top of Dielson Vieira’s mind ever since he joined the Purdue University College of Veterinary Medicine’s faculty in 2024. As a clinical assistant professor in the Department of Basic Medical Sciences, Vieira is already adept at applying innovative teaching practices to classroom environments, but that doesn’t stop him from seeking out new ideas, approaches and perspectives — insights he gains through outlets like Purdue’s teaching and learning reading groups.

Top tier biology journal publishes PVM study that unlocks secrets of a drug-resistant fungal pathogen, which causes serious infections in humans

Though the name “Candida auris” is far from a household term, public health experts know it well because the multi-drug-resistant fungal pathogen, which causes serious human infections, has been classified as an urgent threat by the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Threats Report (2019). Dr. Shankar Thangamani, Associate Professor of Microbiology and University Faculty Scholar in the Purdue University College of Veterinary Medicine’s Department of Comparative Pathobiology, is researching C. auris, aided by a 2.4 million grant from the National Institutes of Health (NIH). New research findings, just published in Nature Microbiology, show how C. auris adapts and evades the immune system.

In Print: ‘Translational Research Methods for Tauopathies’

A just-published 300-page volume edited by Jessica Fortin, Purdue assistant professor in the College of Veterinary Medicine’s Department of Basic Medical Sciences, provides a significant new resource for researchers studying a group of neurodegenerative diseases known as tauopathies. “Translational Research Methods for Tauopathies” provides detailed protocols intentionally selected to serve as a basis for research laboratories seeking to further treatments for such debilitating neurodegenerative diseases as Alzheimer’s and chronic traumatic encephalopathy (CTE).